{"title":"Protein Z Promotes Proliferation in Vascular Endothelial Cell Mediated by Chemokine C-X-C-Motif Receptor 4.","authors":"Peng Zhang, Jie Li, Jingxuan Chen, Xinran Ruan","doi":"10.1620/tjem.2024.J143","DOIUrl":null,"url":null,"abstract":"<p><p>Preeclampsia (PE) is a multisystem progressive disease unique to pregnancy, seriously affecting maternal and infant health. Previous studies have shown that PE is associated with changes in vascular endothelial cells, but the specific mechanism is unclear. In this study, we assessed the effects of chemokine C-X-C-motif receptor 4 (CXCR4) on endothelial cells and explored the potential mechanisms. Human placental microvascular endothelial cells (HPVEC) were exposed to protein Z (PZ), qRT-PCR and Western blotting were used to detect the expression of proliferation related genes and proteins, such as PI3K/Akt/ERK. Meanwhile, qRT-PCR and Western blotting were used to detect the expression of anticoagulation markers PGI2 and t-PA. Then, HPVEC were transfected with CXCR4 siRNA or NC siRNA. The expression of proliferation related genes and proteins were also detected. Finally, PZ and CXCR4 were co-cultivated with different fluorescent labels, the binding sites of the two proteins were observed under confocal laser scanning microscopy (CLSM). PZ promoted the proliferation and expression of anticoagulant markers PGI2 and t-PA in HPVEC. CXCR4 silencing could inhibit the proliferation of HPVEC which stimulated by PZ. CLSM showed that the binding site of PZ and CXCR4 was located on the cell membrane. In conclusion, our results suggested that PZ promote the expression of PGI2/t-PA and affect the PI3K/Akt/ERK signaling pathway by binding with CXCR4 which improved our understanding of the molecular mechanisms involved in HPVEC.</p>","PeriodicalId":23187,"journal":{"name":"Tohoku Journal of Experimental Medicine","volume":" ","pages":"121-125"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tohoku Journal of Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1620/tjem.2024.J143","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Preeclampsia (PE) is a multisystem progressive disease unique to pregnancy, seriously affecting maternal and infant health. Previous studies have shown that PE is associated with changes in vascular endothelial cells, but the specific mechanism is unclear. In this study, we assessed the effects of chemokine C-X-C-motif receptor 4 (CXCR4) on endothelial cells and explored the potential mechanisms. Human placental microvascular endothelial cells (HPVEC) were exposed to protein Z (PZ), qRT-PCR and Western blotting were used to detect the expression of proliferation related genes and proteins, such as PI3K/Akt/ERK. Meanwhile, qRT-PCR and Western blotting were used to detect the expression of anticoagulation markers PGI2 and t-PA. Then, HPVEC were transfected with CXCR4 siRNA or NC siRNA. The expression of proliferation related genes and proteins were also detected. Finally, PZ and CXCR4 were co-cultivated with different fluorescent labels, the binding sites of the two proteins were observed under confocal laser scanning microscopy (CLSM). PZ promoted the proliferation and expression of anticoagulant markers PGI2 and t-PA in HPVEC. CXCR4 silencing could inhibit the proliferation of HPVEC which stimulated by PZ. CLSM showed that the binding site of PZ and CXCR4 was located on the cell membrane. In conclusion, our results suggested that PZ promote the expression of PGI2/t-PA and affect the PI3K/Akt/ERK signaling pathway by binding with CXCR4 which improved our understanding of the molecular mechanisms involved in HPVEC.
期刊介绍:
Our mission is to publish peer-reviewed papers in all branches of medical sciences including basic medicine, social medicine, clinical medicine, nursing sciences and disaster-prevention science, and to present new information of exceptional novelty, importance and interest to a broad readership of the TJEM.
The TJEM is open to original articles in all branches of medical sciences from authors throughout the world. The TJEM also covers the fields of disaster-prevention science, including earthquake archeology. Case reports, which advance significantly our knowledge on medical sciences or practice, are also accepted. Review articles, Letters to the Editor, Commentary, and News and Views will also be considered. In particular, the TJEM welcomes full papers requiring prompt publication.